Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552902 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
A Phase 4 study, sponsored by Shire.
- Completed
- Registry status
- Phase 4
- Development phase
- 549
- Enrollment target
NCT01552902 is a Phase 4 study that has completed, run by Shire. The registered enrollment target is 549 participants.
The verdict
NCT01552902, a Phase 4 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 549 participants
- Enrollment target
Study Summary
The purpose of this study is to determine effectiveness of Vyvanse compared to Concerta in adolescents with Attention-deficit/Hyperactivity Disorder (ADHD).
Interventions
- DRUG Placebo
- DRUG Methylphenidate Hydrochloride
- DRUG Lisdexamfetamine dimesylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 549 participants |
| Start Date | 2012-04-03 |
| Est. Completion | 2014-05-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01552902
The ClinicalTrials.gov registry entry for NCT01552902 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 549 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01552902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01552902 about?
NCT01552902 is a clinical study titled "Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder". The purpose of this study is to determine effectiveness of Vyvanse compared to Concerta in adolescents with Attention-deficit/Hyperactivity Disorder (ADHD).
What is the current status of trial NCT01552902?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 549 participants. The study started on 2012-04-03. Estimated completion is 2014-05-22.
What interventions are being tested in trial NCT01552902?
The interventions under investigation include: Placebo (DRUG), Methylphenidate Hydrochloride (DRUG), Lisdexamfetamine dimesylate (DRUG).
Who is sponsoring clinical trial NCT01552902?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.